Epivir HBV
Epivir HBV

1.07
For patients managing liver viral conditions, this generic medicine blocks viral enzyme activity to reduce the progression of liver-related inflammation.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Lamivudine
Reference Brand
Lamivudine
Product Origin
Generic Brand
Product Manufacturer
ViiV Healthcare
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Antivirals
Product Category
Nucleoside Reverse Transcriptase Inhibitor (NRTI)
Pharmacological Class
Antiviral Agent
Manufacturer Description
Developed to mitigate active hepatitis B replication to support liver cell safety and target viral reverse transcription.
Mechanism of Action
Incorporates into hepatitis B viral DNA to cause chain termination, slowing down the disease process in hepatocytes.
Route of Administration
Oral
Onset Time
2–4 weeks
Duration
24 hours
Contraindications
Severe renal impairment, Hypersensitivity to lamivudine
Severe Adverse Events
Lactic acidosis — requires immediate medical attention, Severe acute hepatitis B flare — requires immediate medical attention
Common Side Effects
Headache, Nausea, Fatigue
Uncommon Side Effects
Elevated liver transaminases, Abdominal pain, Diarrhea
Drug Interactions
Trimethoprim, Tenofovir
Pregnancy Safety Warnings
TGA Category C: Safe during pregnancy. Breastfeeding: Consult a clinician.
Age Restrictions
Approved for children over two years and adults.
Storage Guidelines
Store below 25°C.
Related Products
Information related to Epivir HBV is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to access Hair Regrowth Australia - Regaine Price